{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:04:09Z","timestamp":1789160649289,"version":"build-2803163510"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.jcrs.2009.12.049","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T04:34:56Z","timestamp":1277267696000},"page":"1095-1100","source":"Crossref","is-referenced-by-count":69,"title":["Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantation"],"prefix":"10.1097","volume":"36","author":[{"given":"Eric D.","family":"Donnenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Wittpenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite B.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry D.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"R1-6-20210210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004397-200604630-00012","article-title":"Refractive intraocular lenses; multifocal and phakic IOLs.","volume":"46","author":"Solomon","year":"2006","journal-title":"Int Ophthalmol Clin"},{"issue":"suppl 1","key":"R3-6-20210210","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/ICO.0b013e31812f67ca","article-title":"Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery.","volume":"26","author":"Li","year":"2007","journal-title":"Cornea"},{"key":"R4-6-20210210","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0886-3350(02)01387-1","article-title":"Outcomes of phacoemulsification in patients with dry eye.","volume":"28","author":"Ram","year":"2002","journal-title":"J Cataract Refract Surg"},{"key":"R6-6-20210210","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease; a dose-ranging, randomized trial; the Cyclosporin A Phase 2 Study Group.","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"R7-6-20210210","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1185\/030079905X50615","article-title":"The impact of topical cyclosporine A emulsion 0.05 on the outcomes of patients with keratoconjunctivitis sicca.","volume":"21","author":"Stonecipher","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R9-6-20210210","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.ophtha.2005.05.013","article-title":"Phase III safety evaluation of cyclosporine 0.1 ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.","volume":"112","author":"Barber","year":"2005","journal-title":"Ophthalmology"},{"key":"R10-6-20210210","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajo.2005.10.006","article-title":"The incidence and risk factors for developing dry eye after myopic LASIK.","volume":"141","author":"De Paiva","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R11-6-20210210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00055735-199902000-00011","article-title":"Management of coincident corneal disease and cataract.","volume":"10","author":"Preschel","year":"1999","journal-title":"Curr Opin Ophthalmol"},{"key":"R12-6-20210210","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jcrs.2005.10.034","article-title":"Safety and efficacy of cyclosporine 0.05 drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.","volume":"32","author":"Salib","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"R13-6-20210210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3928\/1081597X-20080501-04","article-title":"The effect of cyclosporine A (Restasis) on recovery of visual acuity following LASIK.","volume":"24","author":"Ursea","year":"2008","journal-title":"J Refract Surg"},{"key":"R15-6-20210210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses.","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R16-6-20210210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine.","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacol"},{"key":"R17-6-20210210","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome; effect on conjunctival lymphocytes.","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R18-6-20210210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00003226-200007000-00018","article-title":"Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion.","volume":"19","author":"Turner","year":"2000","journal-title":"Cornea"}],"container-title":["Journal of Cataract and Refractive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335010005559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0886335010005559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/10.1016\/j.jcrs.2009.12.049","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:29:50Z","timestamp":1786040990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02158034-201007000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jcrs.2009.12.049","relation":{},"ISSN":["0886-3350"],"issn-type":[{"value":"0886-3350","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}